|
|
 |
|
Viewing report
|
|
|
|
Japanese Patient Population Analysis and Epidemiological Survey 2007 Volume 3
Seed Planning, Aug 2007, Pages: 392
Understanding epidemiology in individual countries is an essential factor for the development of strategic business plans for healthcare industries and life insurance companies. Seed Planning, Inc. has devoted to the issuance of epidemiology-related publications for Japan, while sponsoring seminars on this specific topic since 1995. As a part of this consecutive effort, we made revisions to our proprietary Japanese report entitled “Patient Population Analysis and Epidemiological Survey” every three years, which is compiled based on the Japanese MHLW’s statistics, combined with other epidemiological information.
This English written report “Japanese Patient Population Analysis and Epidemiological Survey 2007” was published by Seed Planning, Inc. aiming to provide international companies and organizations with useful information about the Japanese healthcare market. Comprising a total of five volumes, these publications provide nationwide Japanese patient population statistics for all categories of diseases.
This book is designed to benefit people who are involved in searching patient population aiming to assess relevant markets in Japan including:
- Pharmaceutical companies
- Medical equipment manufacturers
- Diagnostics/medical testing equipment manufacturers
- Life insurance companies
The following Tables and Charts are included for each disease indicated in the Table of Contents
1. Estimated number of patients (in thousands)
2. Number of patients receiving medical treatment (in thousands)
3. Number of patients receiving medical treatment, by sex/age group (in thousands)
4. Rates of patients, by age group (per 100,000 population)
5. Trends and forecast of number of patients receiving medical treatment
Diseases covered in this Volume include
- I00-I99 Diseases of the circulatory system
- J00-J99 Diseases of the respiratory system
- K00-K93 Diseases of the digestive system
|
|
|
|
